Patents by Inventor Chie Sugimoto

Chie Sugimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosing fibromyalgia syndrome, and kit therefor
    Patent number: 10156577
    Abstract: The present invention provides a novel marker for diagnosing fibromyalgia syndrome (FMS). More specifically, the present invention provides a method for diagnosing FMS, comprising measurement of (1) the relative frequency of MAITs to the total T cells in a sample; or (2) the expression level of one or more surface antigens selected from the group consisting of CD4, CD8, CCR4, CCR7, CXCR1, NKp80, CD150, CD107a, CD8?, CD44 and CXCR4 for MAITs in a sample, wherein the sample is a biological sample collected from a human; and a diagnosis kit for FMS, comprising a means for measuring (1) the relative frequency of MAITs to the total T cells in a sample; or (2) the expression level of one or more surface antigens selected from the group consisting of CD4, CD8, CCR4, CCR7, CXCR1, NKp80, CD150, CD107a, CD8?, CD44 and CXCR4 for MAITs in a sample, wherein the sample is a biological sample collected from a human.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: December 18, 2018
    Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, MIRACA RESEARCH INSTITUTE G.K.
    Inventors: Hiroshi Wakao, Chie Sugimoto
  • METHOD FOR DIAGNOSING FIBROMYALGIA SYNDROME, AND KIT THEREFOR
    Publication number: 20170097364
    Abstract: The present invention provides a novel marker for diagnosing fibromyalgia syndrome (FMS). More specifically, the present invention provides a method for diagnosing FMS, comprising measurement of (1) the relative frequency of MAITs to the total T cells in a sample; or (2) the expression level of one or more surface antigens selected from the group consisting of CD4, CD8, CCR4, CCR7, CXCR1, NKp80, CD150, CD107a, CD8?, CD44 and CXCR4 for MAITs in a sample, wherein the sample is a biological sample collected from a human; and a diagnosis kit for FMS, comprising a means for measuring (1) the relative frequency of MAITs to the total T cells in a sample; or (2) the expression level of one or more surface antigens selected from the group consisting of CD4, CD8, CCR4, CCR7, CXCR1, NKp80, CD150, CD107a, CD8?, CD44 and CXCR4 for MAITs in a sample, wherein the sample is a biological sample collected from a human.
    Type: Application
    Filed: March 24, 2016
    Publication date: April 6, 2017
    Applicants: National University Corporation Hokkaido University, Fujirebio Inc., SRL, Inc.
    Inventors: Hiroshi WAKAO, Chie Sugimoto